HMR-1372

N/A

Report date: 2025/02/05 13:46:34
NME

Base Information

Drug NameHMR-1372
Drug Alias NameHMR-1372
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKATP channels blockers
TargetsVoltage-gated potassium channel subunit Kv1.3KATP channels
Therapy Area/IndicationsInfarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis Research & Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAventis Research & Technologies
Active IndicationsN/A
Inactive IndicationsInfarction

Other Information

ATC CodeN/A
Related LinksN/A